Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) (NCT06837181)

🧪 Interventions in This Study

• observational study (OTHER)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (18 Sites)

• University of Alabama at Birmingham — Birmingham, Alabama
• Keck Medical Center of USC — Los Angeles, California
• Stanford University — Palo Alto, California
• University of California San Diego — San Diego, California
• University of Colorado Denver — Aurora, Colorado
• University of Miami — Miami, Florida
• Emory University School of Medicine — Atlanta, Georgia
• University of Iowa — Iowa City, Iowa
• Tulane University — New Orleans, Louisiana
• Massachusetts — Boston, Massachusetts
• University of Minnesota — Minneapolis, Minnesota
• University of New Mexico — Albuquerque, New Mexico
• Columbia University Cystic Fibrosis Program — New York, New York
• Atrium Health Wake Forest Baptist (Wake Forest Baptist) — Winston-Salem, North Carolina
• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania
• Medical University of South Carolina — Charlestone, South Carolina
• Baylor College of Medicine — Houston, Texas
• The University of Texas Health Science Center at San Antonio — San Antonio, Texas

📞 Contact the Study Coordinator

Phone: (813) 975-8690

Email: jsibayan@jaeb.org

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Cystic Fibrosis (CF)

• Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta — Denver, Colorado
• Feasibility and Acceptance of SonoHeal for Airway Clearance and Preliminary Comparison With the Standard of Care — Santa Ana, California
• Rethinking Early Airway Clearence Therapies — Birmingham, Alabama
• MRI Assessment of Lung Airways in Cystic Fibrosis: Evaluate MRI's Ability to Detect Changes in Airway Structure . — Toronto, Ontario
• Nutrition Supplement for Cystic Fibrosis — Columbus, Ohio
• Study to Enable New Diagnostics for Pulmonary Microbes in People With CF — La Jolla, California

Explore by condition: All Cystic Fibrosis (CF) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.